semaglutide for alcohol use disorder A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy, can reduce heavy drinking in adults with disorder. Read more: https://www.forbes.com/sites/antoniopequenoiv/2026/07 semaglutide addiction clinical trials Just

Genetic insights complementnot replaceclinical evaluation of your metabolic status, diet, and lifestyle

Energy levels often stabilize as eating patterns adjust

Supplied at 99%+ purity with a batch-specific third-party COA

This residual weight loss corresponds approximately to a 45% reduction in body weight relative to the baseline (at initial weight loss of 1520%) Well, this on the borderline of clinically significant weight loss and probably not enough to sustation CV and other positive effects The best strategy appears to be long term GLP-1 treatment perahps with in lower maintaining doses #obesity #glp1 #treatmentcessation #weightregain #glp1receptoragonist Q

They work best when combined with a healthy diet and regular exercise

Clinical weight loss outcomes The landmark STEP clinical trials established the efficacy of semaglutide 2.4 mg for weight management